Podcast Episodes

Back to Search
Pharmaceutical Executive Daily: FDA has Approved Skinvive by Juvéderm
Pharmaceutical Executive Daily: FDA has Approved Skinvive by Juvéderm

In today's Pharmaceutical Executive Daily, Elicio Therapeutics shares tumble after its Phase II Amplifgy-7P trial of KRAS-targeting immunotherapy ELI…

5 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg
Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg

In today's Pharmaceutical Executive Daily, Boehringer Ingelheim's Brian Hilberdink argues that obesity innovation must evolve beyond the scale, a pha…

5 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO
Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO

In today's Pharmaceutical Executive Daily, Kardigan sets terms for a $350 million IPO that would value the cardiovascular biotech at approximately $1…

5 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: China's Latest Policy Guidance
Pharmaceutical Executive Daily: China's Latest Policy Guidance

In today's Pharmaceutical Executive Daily, Bruce Liu examines China's latest policy guidance establishing premium pricing and priority reimbursement …

5 months, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: Parabilis Medicines Prices Record-Breaking $670 Million IPO
Pharmaceutical Executive Daily: Parabilis Medicines Prices Record-Breaking $670 Million IPO

In today's Pharmaceutical Executive Daily, Parabilis Medicines prices a record-breaking $670 million IPO, Swedish biotech AlzeCure Pharma enters a co…

5 months, 1 week ago

Short Long
View Episode
The Ron Lanton Report: From Innovation to Infrastructure
The Ron Lanton Report: From Innovation to Infrastructure

In this episode, Ron Lanton draws on insights from the JP Morgan Healthcare Conference to explain how healthcare investment is shifting from backing …

5 months, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion
Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion

In today's Pharmaceutical Executive Daily, a pharma funding roundup covers two RNA-focused biotechs that secured fresh capital, GSK announces a $10.6…

5 months, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: Roche and Nurix Therapeutics Announce Global Collaboration
Pharmaceutical Executive Daily: Roche and Nurix Therapeutics Announce Global Collaboration

In today's Pharmaceutical Executive Daily, Roche and Nurix Therapeutics announce a global collaboration, a pharma M&A roundup covers three deals anno…

5 months, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: Supreme Court Unanimously Rules in Favor of Hikma Pharmaceuticals in Skinny Label Case
Pharmaceutical Executive Daily: Supreme Court Unanimously Rules in Favor of Hikma Pharmaceuticals in Skinny Label Case

In today's Pharmaceutical Executive Daily, the Supreme Court unanimously rules in favor of Hikma Pharmaceuticals in its patent dispute with Amarin ov…

5 months, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: Alnylam Pharmaceuticals and Inceptive Nucleics Announce 3 Year Strategic Collaboration
Pharmaceutical Executive Daily: Alnylam Pharmaceuticals and Inceptive Nucleics Announce 3 Year Strategic Collaboration

In today's Pharmaceutical Executive Daily, Eli Lilly escalates its 340B enforcement standoff by notifying covered entities of a five-business-day win…

5 months, 2 weeks ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us